W. Jäger

493 total citations
40 papers, 407 citations indexed

About

W. Jäger is a scholar working on Radiology, Nuclear Medicine and Imaging, Reproductive Medicine and Oncology. According to data from OpenAlex, W. Jäger has authored 40 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Reproductive Medicine and 11 papers in Oncology. Recurrent topics in W. Jäger's work include Ovarian cancer diagnosis and treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HER2/EGFR in Cancer Research (6 papers). W. Jäger is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HER2/EGFR in Cancer Research (6 papers). W. Jäger collaborates with scholars based in Germany, Netherlands and Austria. W. Jäger's co-authors include Stefan Krämer, N. Lang, Gerhard Gebauer, L. Wildt, Nicholas P. Lang, Willi Sauerbrei, Lyndsay N. Harris, John F. R. Robertson, Diana Lüftner and Norbert Lütkenhaus and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Human Reproduction.

In The Last Decade

W. Jäger

39 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Jäger Germany	13	172	118	107	88	78	40	407
Hedda H. van Ravenswaay Claasen Netherlands	7	154 0.9×	127 1.1×	61 0.6×	31 0.4×	43 0.6×	10	401
Violeta R. McGaughy United States	7	148 0.9×	129 1.1×	59 0.6×	58 0.7×	33 0.4×	8	450
Abigail L. Sedlacek United States	11	191 1.1×	111 0.9×	58 0.5×	40 0.5×	28 0.4×	18	477
Antoni Pessarrodona Spain	12	124 0.7×	71 0.6×	36 0.3×	41 0.5×	207 2.7×	27	430
T. Rinda Soong United States	12	124 0.7×	106 0.9×	182 1.7×	20 0.2×	113 1.4×	35	475
Natalie Banet United States	11	135 0.8×	152 1.3×	84 0.8×	20 0.2×	44 0.6×	33	519
P.G. Jayaprakash India	13	130 0.8×	170 1.4×	16 0.1×	87 1.0×	70 0.9×	22	459
SHOJIRO YANO Japan	11	77 0.4×	123 1.0×	48 0.4×	13 0.1×	59 0.8×	32	413
Hideyuki Ohtake Japan	14	115 0.7×	125 1.1×	422 3.9×	130 1.5×	42 0.5×	19	789
Andrew O. Wahl United States	15	120 0.7×	69 0.6×	67 0.6×	154 1.8×	82 1.1×	39	545

Countries citing papers authored by W. Jäger

Since Specialization

Citations

This map shows the geographic impact of W. Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jäger more than expected).

Fields of papers citing papers by W. Jäger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jäger. The network helps show where W. Jäger may publish in the future.

Co-authorship network of co-authors of W. Jäger

This figure shows the co-authorship network connecting the top 25 collaborators of W. Jäger. A scholar is included among the top collaborators of W. Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Jäger. W. Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fehm, Tanja, W. Jäger, S. Kraemer, et al.. (2005). Changes of serum HER2 status during clinical course of metastatic breast cancer patients.. PubMed. 24(6). 4205–10. 16 indexed citations

Krämer, Stefan, et al.. (2004). Operative Therapie des Mammakarzinoms bei älteren Frauen - Erfahrungen aus Erlangen und Nürnberg. Journal für Kardiologie (Krause & Pachernegg GmbH). 11(2). 10–16. 2 indexed citations

Harris, Lyndsay N., Diana Lüftner, W. Jäger, & John F. R. Robertson. (1999). C-erbB-2 in Serum of Patients with Breast Cancer. The International Journal of Biological Markers. 14(1). 8–15. 33 indexed citations

Krämer, Stefan, et al.. (1998). Gonadotropin Levels in Ovarian Cyst Fluids: A Predictor of Malignancy?. The International Journal of Biological Markers. 13(3). 165–168. 14 indexed citations

Hamilton, Gerhard, et al.. (1998). Formation of a novel topotecan metabolite in the hormone-independent human prostate carcinoma cell lines DU-145 and PC-3.. PubMed. 18(4A). 2737–41. 5 indexed citations

Moldenhauer, Anja, E. Merkle, Franklin Kiesewetter, et al.. (1998). CA 125 Production and Release by Ovarian Cancer Cells In Vitro. The International Journal of Biological Markers. 13(4). 200–206. 22 indexed citations

Krämer, Stefan, et al.. (1997). CA 125 is an indicator for pleural metastases in breast cancer.. PubMed. 17(4B). 2967–70. 6 indexed citations

Jäger, W., et al.. (1996). Is screening of metastases based on symptoms effective in breast cancer patients?. PubMed. 16(5B). 3169–71. 1 indexed citations

Beinder, Ernst, et al.. (1995). Partielle Blasenmole bei zytogenetisch unauffälligem Fetus. Geburtshilfe und Frauenheilkunde. 55(6). 351–353. 1 indexed citations

10.

Jäger, W., et al.. (1995). Breast cancer and clinical utility of CA 15—3 and CEA. Scandinavian Journal of Clinical and Laboratory Investigation. 55(sup221). 87–92. 25 indexed citations

11.

Jäger, W., et al.. (1994). Is an increase in CA 125 in breast cancer patients an indicator of pleural metastases?. British Journal of Cancer. 70(3). 493–495. 10 indexed citations

12.

Hofmann, Manuel, et al.. (1994). In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines. Cell Biophysics. 24-25(1-3). 163–173. 5 indexed citations

13.

Sauerbrei, Willi & W. Jäger. (1994). Timing of breast cancer surgery — some arguments that there is no effect. Annals of Oncology. 5(1). 25–27. 12 indexed citations

14.

Jäger, W.. (1993). The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.. PubMed. 2 Suppl 3. 133–9. 18 indexed citations

15.

Jong, Joan de, et al.. (1992). Direct Gold-Silver Method for HCG Binding to Specific Tissue Structures. Journal of Histotechnology. 15(4). 275–281. 4 indexed citations

16.

Recabarren, Sergio E., Ralf Dittrich, W. Jäger, & L. Wildt. (1991). Plasma luteinizing hormone bioactivity and immunoactivity in ovariectomized rats treated with a long-acting agonist of luteinizing hormone releasing hormone. Human Reproduction. 6(7). 928–930. 4 indexed citations

17.

Jäger, W., et al.. (1990). The influence of maternal exercise on the pulsatility index of the umbilical artery blood velocity waveform. European Journal of Obstetrics & Gynecology and Reproductive Biology. 37(1). 1–6. 9 indexed citations

18.

Hoogland, H.J., et al.. (1990). Characteristics of the Umbilical Artery Velocity Waveform as Function of Measurement Site. Gynecologic and Obstetric Investigation. 30(4). 212–216. 6 indexed citations

19.

Jäger, W., et al.. (1989). Immunhistochemischer und serologischer Nachweis des CA-125 bei Patientinnen mit Peritonealtuberkulose und Aszites. Geburtshilfe und Frauenheilkunde. 49(1). 61–63. 9 indexed citations

20.

Jäger, W., L. Wildt, & N. Lang. (1989). Some observations on the effect of a GnRH analog in ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 32(2). 137–148. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact